Literature DB >> 22459813

Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet.

J Wang1, H Zhang, X Chen, Y Chen, Q Bao.   

Abstract

The objectives of this study were to screen probiotic characteristics of lactobacilli isolated from traditionally homemade koumiss products in Xinjiang and Inner Mongolia of China, and to determine and compare the effect of the Lactobacillus strains in vivo on lipid metabolism in rats fed with a high-lipid diet. Three out of 68 strains of Lactobacillus isolated from the koumiss were screened for bile-salt resistance, acid tolerance, and different hypocholesterolemic properties. The cholesterol-lowering effects of the 3 screened strains were estimated in rats fed a high-lipid diet by determination of serum lipids, liver, and fecal cholesterol, fecal total bile acids, and short-chain fatty acids. After a 4-wk feeding period, in comparison with the control group, the groups LIP-1 and MG9-2 had a significant reduction in serum total cholesterol, triglyceride and low-density lipoprotein cholesterol, and significantly increased high-density lipoprotein, the group E7301 had similar effects on serum lipids, but the change was not significant. The groups LIP-1, MG9-2 and E7301 had a significant reduction in liver cholesterol content and an increase in fecal cholesterol content compared with the control group. Total bile acid excretion was significantly higher in rats fed MG9-2 than the other groups. Rats fed diets containing lactic acid bacteria strains had significantly higher propionic acid and butyric acid concentrations in the feces compared with the control. Results indicated that the 3 screened Lactobacillus strains were able to lower cholesterol in vitro, and reduce cholesterol effectively in vivo. The mechanisms behind the hypocholesterolemic effect of 3 strains are likely to be diverse and will need further investigation.
Copyright © 2012 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22459813     DOI: 10.3168/jds.2011-4768

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  27 in total

1.  Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells.

Authors:  Taiji Mizoguchi; Kazuyuki Kasahara; Tomoya Yamashita; Naoto Sasaki; Keiko Yodoi; Takuya Matsumoto; Takuo Emoto; Tomohiro Hayashi; Naoki Kitano; Naofumi Yoshida; Hilman Zulkifli Amin; Ken-Ichi Hirata
Journal:  Heart Vessels       Date:  2017-02-08       Impact factor: 2.037

Review 2.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.

Authors:  Junli Ma; Qihang Zhou; Houkai Li
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

3.  Selection of Cholesterol-Lowering Lactic Acid Bacteria and its Effects on Rats Fed with High-Cholesterol Diet.

Authors:  Yufang Liu; Fengchun Zhao; Jiye Liu; Huimin Wang; Xiao Han; Yongxin Zhang; Zhengyou Yang
Journal:  Curr Microbiol       Date:  2017-03-13       Impact factor: 2.188

4.  Effects of lactic acid bacteria isolated from fermented mustard on lowering cholesterol.

Authors:  Shu Chen Wang; Chen Kai Chang; Shu Chang Chan; Jiunn Shiuh Shieh; Chih Kwang Chiu; Pin-Der Duh
Journal:  Asian Pac J Trop Biomed       Date:  2014-07

5.  Acute oral treatment with resveratrol and Lactococcus Lactis Subsp. Lactis decrease body weight and improve liver proinflammatory markers in C57BL/6 mice.

Authors:  Keila Lopes Mendes; Deborah de Farias Lelis; Daniela Fernanda de Freitas; Luiz Henrique da Silveira; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães; Janaína Ribeiro Oliveira; Mariléia Chaves Andrade; Sérgio Avelino Mota Nobre; Sérgio Henrique Sousa Santos
Journal:  Mol Biol Rep       Date:  2021-02-14       Impact factor: 2.316

6.  Revealing Probiotic Potential of Enterococcus Strains Isolated From Traditionally Fermented Chhurpi and Healthy Human Gut.

Authors:  Kriti Ghatani; Subarna Thapa; Shankar Prasad Sha; Sourav Sarkar; Debabrata Modak; Soumen Bhattacharjee
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

7.  Colonization and Gut Flora Modulation of Lactobacillus kefiranofaciens ZW3 in the Intestinal Tract of Mice.

Authors:  Zhuqing Xing; Wei Tang; Ying Yang; Weitao Geng; Rizwan Ur Rehman; Yanping Wang
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

8.  Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice.

Authors:  Rostyslav Bubnov; Lidiia Babenko; Liudmyla Lazarenko; Maryna Kryvtsova; Oleksandr Shcherbakov; Nadiya Zholobak; Olga Golubnitschaja; Mykola Spivak
Journal:  EPMA J       Date:  2019-10-29       Impact factor: 6.543

9.  Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice.

Authors:  Rostyslav V Bubnov; Lidiia P Babenko; Liudmyla M Lazarenko; Viktoria V Mokrozub; Oleksandr A Demchenko; Oleksiy V Nechypurenko; Mykola Ya Spivak
Journal:  EPMA J       Date:  2017-10-10       Impact factor: 6.543

10.  How much in vitro cholesterol reducing activity of lactobacilli predicts their in vivo cholesterol function?

Authors:  Golnoush Madani; Maryam Mirlohi; Mahmoud Yahay; Akbar Hassanzadeh
Journal:  Int J Prev Med       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.